Tazocin (pipercillin/tazobactam)

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, Ain Shams University

Conditions

Bacterial InfectionsSepsis

Phase 1

Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn Patients

Active, not recruitingNCT07096310

Ain Shams UniversitySepsis

Start: 2024-01-01End: 2026-03-01Target: 400Updated: 2025-10-03

Phase 4

Study Evaluation Tazocin Intervention

CompletedNCT00488189

Wyeth is now a wholly owned subsidiary of PfizerBacterial Infections

Start: 2007-05-31End: 2008-02-29Updated: 2011-04-15